Taipei Medical University

Bioenergetics and Reproductive Medicine

Shu-Huei Kao
https://hub.tmu.edu.tw/en/persons/shu-huei-kao

Research Field

Medicine

Introduction

Dr. Shu-Huei Kao received her doctoral degree in Biochemistry and Molecular Biology, emphasizing mitochondrial health in human reproduction in 2002 from the National Yang-Ming University, Taiwan. Then, she joined Taipei Medical University (TMU) as a tenure-track Assistant Professor in 2000 and was promoted to Associate Professor in 2008 and full Professor in 2019. 

She is currently a Professor at the School of Medical Laboratory Science and Biotechnology. She is the Vice Dean for Education Affairs of the College of Medical Science and Technology (COMST) at Taipei Medical University, Taiwan. She is dedicated to diagnosis of the rare diseases and reproductive technology-assisted treatments.

Academic Experience and Administrative Experience

  • 2023- Professor and Vice Dean, School of Medical Laboratory Science and Biotechnology, Taipei Medical University Joint-Appointment Professor, Ph. D Program in Medical Biotechnology, Taipei Medical University
  • 2019- 2022 Professor and Director, School of Medical Laboratory Science and Biotechnology, Taipei Medical University Joint-Appointment Professor, Ph. D Program in Medical Biotechnology, Taipei Medical University                    
  • 2017- Associate Professor and Director, School of Medical Laboratory Science and Biotechnology, Taipei Medical University Joint-Appointment Associate Professor, Ph. D Program in Medical Biotechnology, Taipei Medical University
  • 2015-2017 Associate Professor, School of Medical Laboratory Science and Biotechnology, Taipei Medical University Joint-Appointment Associate Professor, Ph. D Program in Medical Biotechnology, Taipei Medical University
  • 2008-2017 Associate Professor, School of Medical Laboratory Science and Biotechnology, Taipei Medical University
  • 2004-2008 Assistant Professor, School of Medical Laboratory Science and Biotechnology, Taipei Medical University
  • 1999-2003 Adjunct Assistant Professor, Department of Molecular Science and Engineering, National Taipei Technical University
  • 2000-2004 Assistant Professor, Graduate Institute of Medical Technology, Taipei Medical University

My research goals have been and remain specific to understanding the associations between mitochondrial medicine in human reproduction and rare diseases. My major work is to develop a molecular diagnosis of mitochondrial diseases and the applicability of reproductive technology-assisted treatments. 


Research Topics

1. Oxidative Stress and Mitochondrial Health in Male Reproductive Health.

 Male infertility is a growing problem that affects 30% of infertile human couples due to a decline in sperm counts and a rise in testicular and sperm anomalies. The evaluation of male factor infertility has become more important and informative since new diagnostic techniques and therapeutic options have become available. The respiratory dysfunction of mitochondria probably causes a decline in motility. We suggested that redox control in the mitochondrial microenvironment is essential for proper sperm motility and fertility.

2. Estrogen Receptor contributes to Human Disease.  

Estrogen is the major regulator of cellular growth, energy production, biogenesis, and apoptosis. Estrogen enhances mitochondrial function by enhancing mitochondrial biogenesis and sustaining mitochondrial energy–transducing capacity. Studies have shown that mitochondria are an important target of estrogen. Estrogen receptor-beta (ERβ) has been shown to localize to mitochondria in a ligand-dependent or --independent manner and can affect mitochondrial bioenergetics and anti-apoptotic signaling. 

3. Mitochondrial Health in Female Reproduction. 

Mitochondria are vital organelles involved in cellular energy production and programmed cell death. Concurrently, mitochondria are the central sites for steroid hormone biosynthesis. The first and rate-limiting step in the biosynthesis of steroid hormones occurs in the mitochondria of granulosa cells. In the present study, we hypothesized that the mitochondria in granulosa cells are critical for maintaining oocyte quality and fertility capacity. We found mitochondrial dysfunction of human granulosa cells may contribute to the decline of steroidogenesis, decreased fertilization rate, oocyte maturation rate, and oocyte quality, and it can ultimately jeopardize fertility. 

4.  Mitochondrial Health in Human Diseases 

As the center organelle of the intrinsic apoptotic pathways, mitochondria are the reservoir of proapoptotic factors. Impairing mitochondrial function causes cell death by compromising ATP production, calcium homeostasis and increasing oxidative stress. Therefore, mitochondrial dysfunction is rationally suspected to be a causal link to human diseases. In addition, mitochondrial dysfunction occurs when the mitochondria don't work as well as they should due to another disease or condition. Many conditions can lead to secondary mitochondrial dysfunction and affect several human diseases. Recently, we tried to understand the role of mitochondria in metabolic disease and mitochondrial diseases.


Honor
  • 2015   College Student Research Creativity Award, Ministry of Science and Technology, Taiwan
  • 1995   Mr. Hsun-Ruo YIN Educational Foundation Memorial Scholarship

Best Poster Award

  • 2023   Best Award for Poster Presentation, DiscoverMito, 2023 Annual Conference of Taiwan Society for Mitochondrial Research and Medicine, Tainan, Taiwan.
  • 2023   Best Award for Poster Presentation, 2023 Annual Conference of American Society for Reproductive Medicine, New Orleans, Louisiana, USA.
  • 2023   Best Award for Poster Presentation, Pan Pacific Symposium on Stem Cells and Cancer Research, Hualien, Taiwan
  • 2021    Best Award for Poster Presentation, Mitochondrial Pathophysiology and Mitochondria-Targeted Medicine, 2021 Annual Conference of Taiwan Society for Mitochondrial Research and Medicine
  • 2018.   Best Award for Poster Presentation, 15th Conference of the Asian Society for Mitochondrial Research and Medicine (ASMRM), Nov 7-8, 2018. Busan, Korea. (Best Award for Poster Presentation)
  • 2016.   Best Award for Poster Presentation, 5th International Conference and Exhibition on Metabolomics. May 16-18, 2016. Osaka, Japan. (Best Award for Poster Presentation)
  • 2014.  Best Award for Poster Presentation, 11th Conference of the Asian Society for Mitochondrial Research and Medicine (ASMRM), 2014, Nov, 14-Nov. 15, Taipei, Taiwan, Poster 14. (Best Award for Poster Presentation)
  • 2014.  Best Award for Poster Presentation, 11th Conference of the Asian Society for Mitochondrial Research and Medicine (ASMRM), 2014, Nov, 14-Nov. 15, Taipei, Taiwan, Poster 50. (Best Award for Poster Presentation)
  • 2014.  Best Award for Poster Presentation, 11th Conference of the Asian Society for Mitochondrial Research and Medicine (ASMRM), 2014, Nov, 14-Nov. 15, Taipei, Taiwan, Poster 78. (Best Award for Poster Presentation)
  • 2012  Best Award for Poster Presentation, 7th International Symposium on Genomic Medicine of CCH; 2012 Symposium of Taiwan Society for Mitochondrial Research and Medicine; 2012 Symposium of Australasian College of Medical Sciences and Research, Oct 26-27, ChangHwa, Poster 4. (Best Poster Award-Gold Medal Award)
  • From 2012

Educational Background

1998, PhD., Biochemistry and Molecular Biology, National Yang-Ming University, Taiwan

1991, MS, Biochemistry and Molecular Biology, National Yang-Ming University, Taiwan

1987, BS, Medical Technology, Taipei Medical University